{
    "title": "109_hr3568",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Angie Fatino Save Our Children from \nMeth Act of 2005''.\n\nSEC. 2. SCHEDULES OF CONTROLLED SUBSTANCES; TRANSFER OF EPHEDRINE, \n              PSEUDOEPHEDRINE, AND PHENYLPROPANOLAMINE TO SCHEDULE V.\n\n    (a) In General.--The Controlled Substances Act (21 U.S.C. 801 et \nseq.) is amended by inserting after section 202 the following section:\n\n``SEC. 202A. SCHEDULING OF EPHEDRINE, PSEUDOEPHEDRINE, AND \n              PHENYLPROPANOLAMINE.\n\n    ``(a) Schedule V.--With respect to schedule V of the schedules of \ncontrolled substances established under section 202(c), the Attorney \nGeneral shall by regulation, not later than 90 days after the date of \nthe enactment of the Angie Fatino Save Our Children from Meth Act of \n2005, transfer to such schedule the following chemicals, subject to \nsubsection (b):\n            ``(1) Ephedrine.\n            ``(2) Pseudoephedrine.\n            ``(3) Phenlypropanolamine.\n            ``(4) Each of the salts, optical isomers, and salts of \n        optical isomers of the chemicals specified in paragraphs (1) \n        through (3).\n    ``(b) Pseudoephedrine in Certain Products; Continued Regulation as \nList I Chemical.--Subject to the authority of the Attorney General \nunder this Act to designate substances as controlled substances or \nlisted chemicals:\n            ``(1) Subsection (a) does not apply to pseudoephedrine when \n        contained in a product that--\n                    ``(A) is in the form of a liquid, liquid capsule, \n                or liquid-filled gel capsule;\n                    ``(B) does not contain more than 360 milligrams of \n                pseudoephedrine; and\n                    ``(C) is approved under section 505 of the Federal \n                Food, Drug, and Cosmetic Act.\n            ``(2) Pseudoephedrine, when contained in such a product, \n        shall be considered a list I chemical.''.\n    (b) Definitions.--Section 102 of the Controlled Substances Act (21 \nU.S.C. 102) is amended by adding at the end the following paragraph:\n            ``(46)(A) The term `pseudoephedrine' includes each of the \n        salts, optical isomers, and salts of optical isomers of \n        pseudoephedrine.\n            ``(B) The term `schedule V pseudoephedrine product' means a \n        product that contains pseudoephedrine and--\n                    ``(i) is not a list I pseudoephedrine product; and\n                    ``(ii) is approved under section 505 of the Federal \n                Food, Drug, and Cosmetic Act.\n            ``(C) The term `list I pseudoephedrine product' means a \n        product that contains pseudoephedrine and is described in \n        section 202A(b)(1).''.\n\nSEC. 3. REGULATION OF PSEUDOEPHEDRINE AS LIST I CHEMICAL; EXCEPTIONS \n              FROM DEFINITION OF REGULATED TRANSACTION; CONFORMING \n              AMENDMENTS REGARDING SCHEDULE V PRODUCTS.\n\n    (a) In General.--Section 102 of the Controlled Substances Act (21 \nU.S.C. 802) is amended--\n            (1) in paragraph (39)(A), by amending clause (iv) to read \n        as follows:\n                    ``(iv)(I) subject to to subclause (II), any \n                transaction in a listed chemical that is contained in a \n                drug that may be marketed or distributed lawfully in \n                the United States under the Federal Food, Drug, and \n                Cosmetic Act unless--\n                            ``(aa) the Attorney General has determined \n                        under section 204 that the drug or group of \n                        drugs is being diverted to obtain the listed \n                        chemical for use in the illicit production of a \n                        controlled substance; and\n                            ``(bb) the quantity of the listed chemical \n                        contained in the drug included in the \n                        transaction or multiple transactions equals or \n                        exceeds the threshold established for that \n                        chemical by the Attorney General; or\n                    ``(II) any transaction in a list I pseudoephedrine \n                product, unless the Attorney General has determined \n                under section 204 that the product is being diverted to \n                obtain pseudoephedrine for use in the illicit \n                production of a controlled substance; or'';\n            (2) by striking paragraph (45); and\n            (3) by redesignating the paragraph (46) that relates to \n        retail distributor as paragraph (45).\n    (b) Conforming Amendment.--Section 310(b)(3)(D)(ii) of the \nControlled Substances Act (21 U.S.C. 830(b)(3)(D)(ii)) is amended by \nstriking ``102(46)'' and inserting ``102(45)''.\n\nSEC. 4. RESTRICTIONS ON NONPRESCRIPTION RETAIL SALES OF PSEUDOEPHEDRINE \n              PRODUCTS.\n\n    (a) List I and Schedule V Products; Registration Conditions.--\nSection 303 of the Controlled Substances Act (21 U.S.C. 823) is amended \nby adding at the end the following subsection:\n    ``(i)(1) With respect to list I pseudoephedrine products, a \nregistration under this section that includes authority for the sale of \nsuch products at retail (including a registration for a pharmacy) shall \nprovide that, for the general physical location for which the \nregistration is issued, the registration is subject to the following \nconditions:\n            ``(A) In offering the products for sale, the registrant \n        places the products such that customers do not have direct \n        access to the products (commonly known as behind the counter).\n            ``(B) The registrant does not sell such a product that is \n        in the form of a package that can be further broken down or \n        subdivided into two or more separate and distinct packages.\n            ``(C) The registrant does not knowingly sell to an \n        individual more than one such product during a 24-hour period.\n            ``(D) The registrant maintains a written list of sales of \n        such products that identifies the products, the purchasers, and \n        the dates and times of the sales (which list is referred to in \n        this subsection as the `logbook').\n            ``(E) The registrant does not sell such a product unless--\n                    ``(i) the prospective purchaser--\n                            ``(I) is 18 years of age or older;\n                            ``(II) presents an identification card that \n                        provides a photograph and is issued by a State \n                        or the Federal Government; and\n                            ``(III) legibly signs the logbook and \n                        prints in the logbook his or her name, address, \n                        and the date and time of the sale; and\n                    ``(ii) the registrant determines that the name \n                signed and printed in the logbook corresponds to the \n                name provided on such identification and that the date \n                and time entered are correct.\n            ``(F) After a volume of the logbook is full, the registrant \n        maintains possession of the volume for not fewer than 12 months \n        after the date of the last sale entered in the logbook.\n            ``(G) The registrant does not offer a promotion in which, \n        as part of a purchase transaction, such a product is provided \n        without charge.\n            ``(H) On the premises of the location, the registrant posts \n        a clear and conspicuous notice providing as follows: `Federal \n        law prohibits the over-the-counter purchase of more than one \n        product containing pseudoephedrine in a 24-hour period, and \n        prohibits the over-the-counter purchase of more than 7,500 \n        milligrams of pseudoephedrine within a 30-day period. If you \n        make an over-the-counter purchase of such a product, you are \n        required to sign a logbook that may be accessible to law \n        enforcement officers.'.\n    ``(2) With respect to schedule V pseudoephedrine products that do \nnot require prescriptions, a registration under this section for a \npharmacy shall provide that, for the general physical location \ninvolved, the registration is subject to the following conditions:\n            ``(A) The registrant does not dispense such a product \n        unless--\n                    ``(i) the prospective purchaser is 18 years of age \n                or older; and\n                    ``(ii) in any case in which the prospective \n                purchaser is not known to the pharmacist involved, such \n                purchaser presents an identification card that provides \n                a photograph, is issued by a State or the Federal \n                Government, and indicates the age of such purchaser.\n            ``(B) The registrant maintains a record for the dispensing \n        of such a product that contains, for each sale of the product--\n                    ``(i) the name and address of the purchaser;\n                    ``(ii) the name and quantity of the product \n                purchased;\n                    ``(iii) the date of the purchase; and\n                    ``(iv) the name or unique identification of the \n                pharmacist involved.\n            ``(C) The record under subparagraph (B) is in one or more \n        of the following forms:\n                    ``(i) A hard-copy record.\n                    ``(ii) A record in an electronic prescription-\n                dispensing system.\n                    ``(iii) A record in an electronic data collection \n                system that contains the information required in this \n                subparagraph and that is capable of producing a hard-\n                copy printout of the record.''.\n    (b) Penalties.--Section 402(a) of the Controlled Substances Act (21 \nU.S.C. 842(a)) is amended--\n            (1) in paragraph (10), by striking ``or'' after the \n        semicolon at the end;\n            (2) in paragraph (11), by striking the period at the end \n        and inserting ``; or''; and\n            (3) by inserting after paragraph (11) the following \n        paragraph:\n            ``(12) who is a registrant to violate any of the \n        registration conditions described in section 303(i) (relating \n        to the sale of list I and schedule V pseudoephedrine \n        products).''.\n\nSEC. 5. RESTRICTIONS ON PURCHASES OF PSEUDOEPHEDRINE.\n\n    Section 404(a) of the Controlled Substances Act (21 U.S.C. 844(a)) \nis amended by inserting after the second sentence the following: ``It \nshall be unlawful for any person to knowingly or intentionally purchase \nat retail without a prescription more than one list I pseudoephedrine \nproduct during a 24-hour period, or to knowingly or intentionally \npurchase such a product at retail without legibly signing the \nappropriate logbook referred to in section 303(i)(1)(D). It shall be \nunlawful for any person to knowingly or intentionally purchase at \nretail without a prescription more than 7,500 milligrams of \npseudoephedrine in list I or schedule V pseudoephedrine products during \na 30-day period.''."
}